These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18073451)

  • 1. Cardiovascular risk and risk management in HIV-infected patients.
    Adeyemi O
    Top HIV Med; 2007; 15(5):159-62. PubMed ID: 18073451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on cardiovascular complications in HIV infection.
    Currier JS
    Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.
    Top HIV Med; 2010 Dec; 18(5):164-8. PubMed ID: 21245517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dyslipidemia and other cardiovascular risk factors in HIV-infected patients: case-based review.
    Aberg JA
    Top HIV Med; 2006; 14(4):134-9. PubMed ID: 17114827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of common chronic metabolic complications in HIV-infected patients.
    Bader MS; Kelly DV
    Postgrad Med; 2008 Nov; 120(4):17-27. PubMed ID: 19020362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and HIV infection: host, virus, or drugs?
    Martínez E; Larrousse M; Gatell JM
    Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When to start antiretroviral therapy: a swinging pendulum?
    Gallant JE
    Top HIV Med; 2008; 16(2):82-8. PubMed ID: 18591715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.
    Deeks SG
    Top HIV Med; 2009; 17(4):118-23. PubMed ID: 19890183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage liver disease in HIV disease.
    Peters MG
    Top HIV Med; 2009; 17(4):124-8. PubMed ID: 19890184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
    Carosi G; Quiros-Roldan E; Torti C; Antinori A; Bevilacqua M; Bonadonna RC; Bonfanti P; Castagna A; Cauda R; d'Arminio-Monforte A; Di Gregorio P; Di Perri G; Esposito R; Fatuzzo F; Gervasoni C; Giannattasio C; Guaraldi G; Lazzarin A; Lo Caputo S; Maggi P; Mazzotta F; Moroni M; Prestileo T; Ranieri R; Rizzardini G; Russo R; Galli M;
    Infection; 2007 Jun; 35(3):134-42. PubMed ID: 17565453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular manifestations in human immunodeficiency virus-infected patients.
    Khunnawat C; Mukerji S; Havlichek D; Touma R; Abela GS
    Am J Cardiol; 2008 Sep; 102(5):635-42. PubMed ID: 18721528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease in HIV infection.
    Sudano I; Spieker LE; Noll G; Corti R; Weber R; Lüscher TF
    Am Heart J; 2006 Jun; 151(6):1147-55. PubMed ID: 16781213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
    Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
    J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of hepatitis B virus and HIV coinfection.
    Peters MG
    Top HIV Med; 2007; 15(5):163-6. PubMed ID: 18073452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non--AIDS-defining malignancies in HIV.
    Mitsuyasu RT
    Top HIV Med; 2008; 16(4):117-21. PubMed ID: 18838745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.
    Baekken M; Os I; Sandvik L; Oektedalen O
    J Hypertens; 2008 Nov; 26(11):2126-33. PubMed ID: 18854751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated vascular diseases: structural and functional changes, clinical implications.
    Monsuez JJ; Charniot JC; Escaut L; Teicher E; Wyplosz B; Couzigou C; Vignat N; Vittecoq D
    Int J Cardiol; 2009 Apr; 133(3):293-306. PubMed ID: 19131130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal dysfunction and tenofovir toxicity in HIV-infected patients.
    Szczech LA
    Top HIV Med; 2008; 16(4):122-6. PubMed ID: 18838746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.